Experience of the successful treatment with canakinumab of a patient with NLPC4-associated autoinflammatory syndrome with enterocolitis

Experience of the successful treatment with canakinumab of a patient with NLPC4-associated autoinflammatory syndrome with enterocolitis

The article shows the observation of rare NLPC4-associated autoinflammatory syndrome with enterocolitis and familial cold urticaria. Diagnosis is confirmed molecularly-genetically: previously not described mutation c.928C>T in the heterozygous state in NLRC4 gene is discovered by a method of...

Full description

Bibliographic Details
Main Authors: T. V. Sleptsova, E. I. Alexeeva, K. V. Savost’yanov, A. A. Pushkov, T. M. Bzarova, S. I. Valieva, O. L. Lomakina, R. V. Denisova, K. B. Isaeva, E. G. Chistyakova
Format: Article
Language:English
Published: Paediatrician Publishers, LLC 2016-06-01
Series:Pediatričeskaâ Farmakologiâ
Subjects:
children
autoinflammatory syndromes
nlrc4
autoinflammatory syndrome with enterocolitis
canakinumab
human monoclonal antibody
interleukin-1
Online Access:https://www.pedpharma.ru/jour/article/view/1404

Internet

https://www.pedpharma.ru/jour/article/view/1404

Similar Items